Investorideas.com

Get investor ideas from our AI, cannabis, cleantech, crypto, gaming, mining, sports podcasts - be a guest or sponsor: call 800 665 0411

 


BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks

BiotechIndustryStocks.com - investing ideas in biotechnology stocks, medical technology, telemedicine, Covid-19

Like Biotech Stocks? View our Biotech Stocks Directory    Get News Alerts on Biotech Stocks


Featured Biotech stocks - Feature Your Company & Product Here

Biotech News

New Stocks to Watch - Biotech (NasdaqGS: ERAS) (Nasdaq: TCRX) (Nasdaq: HCWB), Mining (CSE: GMR) (CSE: ATHA) Cannabis (CSE: XBRA)
Point Roberts, WA and Delta, BC - October 22, 2021 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Biotech, Mining and Cannabis.

Radius Health Reports Positive Topline Data from Ph. 3 Metastatic Breast Cancer Trial
October 21, 2021 (Investorideas.com Newswire) Shares of Radius Health Inc. traded 17% higher after the firm reported positive topline results from the Phase 3 EMERALD study of elacestrant in ER+/HER2- advanced or metastatic breast cancer (mBC).

New French Vaccine May 'Play an Important Role in Overcoming' COVID-19
October 19, 2021 (Investorideas.com Newswire) Valneva SE shares traded 40% higher after the company reported positive results from its Phase 3 clinical trial of its COVID-19 vaccine candidate, VLA2001.

DarioHealth Contracts with National Health Plan to Offer Behavioral Health Services to Millions of Members
October 15, 2021 (Investorideas.com Newswire) DarioHealth Corp. shares traded 17% higher after the company reported it entered into an agreement with an unnamed national healthcare provider to make its behavioral health products available to millions of the plan's members.

Pacira Bids to Acquire Flexion to Expand Leadership Position in Non-Opioid Pain Management
October 12, 2021 (Investorideas.com Newswire) Flexion Therapeutics Inc. shares traded 60% higher after the company reported it entered into a definitive agreement to be acquired by Pacira BioSciences Inc.

ChemoCentryx Shares Double After FDA Approves TAVNEOS for Treatment of ANCA-Associated Vasculitis
October 11, 2021 (Investorideas.com Newswire) Shares of ChemoCentryx Inc. traded 96% higher after the company reported the U.S. FDA approved its orally administered TAVNEOS (avacopan) for use in treatment of ANCA-associated vasculitis

Reliq's Telemedicine Platform Helps Free Up Hospital Space for COVID-19 Delta Patients
October 7, 2021 (Investorideas.com Newswire) Simultaneously, demand is growing for Reliq Health's iUGO Care software as virtual healthcare delivery increases during the COVID-19 pandemic.

Voyager Shares Lift Off After Firm Signs License Deal With Pfizer for Next-Gen AAV Capsids for Gene Therapy Programs
October 7, 2021 (Investorideas.com Newswire) Shares of Voyager Therapeutics Inc. traded 51% higher after the company reported it entered into a license and option agreement with Pfizer Inc. for two of its TRACER AAV capsids

SmileDirectClub Granted Patent for Mobile Oral Care Bus to Serve Remote Regions in the US & UK
October 6, 2021 (Investorideas.com Newswire) SmileDirectClub Inc. shares traded 15% higher after the company reported that the U.S. Patent & Trademark Office has allowed its new patent for the firm's mobile SmileBus concept whereby its SmileShop on wheels is mobilized to expand access to convenient, affordable oral care in remote areas across the U.S. and the U.K.

Xenon Pharma Shares Gain 80% on Positive Data in Phase 2b Focal Epilepsy Trial
October 5, 2021 (Investorideas.com Newswire) Shares of Xenon Pharmaceuticals Inc. soared to a new 52-week high after the company reported topline data from its Phase 2b X-TOLE clinical study demonstrating that its epilepsy drug candidate XEN1101 successfully met several primary and secondary efficacy endpoints

Subscribe to Biotech News RSS

Submit Articles   Search More Articles

Biotech Stock ETF's

First Trust NYSE Arca Biotech ETF ( NYSEArca: FBT ) The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified.

iShares US Healthcare ( NYSEArca: IYH ) The investment seeks to track the investment results of an index composed of U.S. equities in the healthcare sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Health Care Index (the "underlying index"), which measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.

iShares US Healthcare Providers ( NYSEArca: IHF ) The investment seeks to track the investment results of an index composed of U.S. equities in the healthcare providers sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Select Health Care Providers Index (the "underlying index"), which measures the performance of the healthcare providers sector of the U.S. equity market. The fund is non-diversified.

iShares US Medical Devices ( NYSEArca: IHI ) The investment seeks to track the investment results of an index composed of U.S. equities in the medical devices sector. The fund seeks to track the investment results of the Dow Jones U.S. Select Medical Equipment Index (the "underlying index"), which measures the performance of the medical equipment sector of the U.S. equity market. The underlying index includes medical equipment companies such as manufacturers and distributors of medical devices such as magnetic resonance imaging (MRI) scanners, prosthetics, pacemakers, X-ray machines, and other non-disposable medical devices. The fund is non-diversified.

iShares Nasdaq Biotechnology ( NasdaqGIDS IBB ) The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by the NASDAQ OMX Group, Inc. The fund is non-diversified.

Market Vectors Biotech ETF ( NYSE MKT:BBH ) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

PowerShares Dynamic Biotech & Genome ETF ( NYSEArca: PBE ) The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Biotechnology & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

Related Guest Posts

Buy a guest post on Investorideas.com

Biotech News from Newsfile

Awakn Life Sciences to Present at the Benzinga Global Small Cap Conference
Toronto, Ontario--(Newsfile Corp. - October 22, 2021) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing and delivering psychedelic therapeutics (medicines and therapies) to treat addiction, announced today that Chief Executive Officer, Anthony Tennyson, will present a corporate overview at the Benzinga Global Small Cap Conference, which is being held virtually on October 27 - 28, 2021.Mr. Tennyson will deliver his presentation on Wednesday October 27, 2021 at...

American Aires Launches New "LIFETUNE MINI" Product in Advance of 2021 Holiday Season
Toronto, Ontario--(Newsfile Corp. - October 21, 2021) - American Aires Inc. (CSE: WIFI) (the "Company" or "Aires") is extremely pleased to confirm the launch of a new product, the "LIFETUNE MINI" in advance of the upcoming 2021 holiday season. With the new LIFETUNE MINI, customers will have the opportunity to benefit from "portable / wearable" protection against the harmful effects of electromagnetic radiation (EMR) / electromagnetic frequency (EMF).Launching the new LIFETUNE MINI marks an exciting...

BioHarvest Sciences Inc. Announces Appointment of David Tsur to Board of Directors
David Tsur's 40 years of Biotech experience further strengthens the Board at a critical phase of the Company's growthHis appointment reinforces the Company's primary focus on becoming a Biotech leader, leveraging the power of its platform technology to disrupt multiple business verticals Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 21, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company") today announced that David Tsur has agreed to serve as a non-executive...

Tryp Therapeutics Reports Clinical Hold on Proposed Phase 2a Study in Eating Disorders
San Diego, California--(Newsfile Corp. - October 20, 2021) - Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, today announced that the U.S. Food and Drug Administration ("FDA") has placed a clinical hold on the Company's Phase 2a study for eating disorders that includes binge eating disorder and hypothalamic obesity. The notification from the FDA did not provide a...

PharmaDrug Commences Trading on the OTCQB Market in the United States
Toronto, Ontario--(Newsfile Corp. - October 20, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce it has qualified for trading on the OTCQB Venture Market (the "OTCQB") operated by the OTC Markets Group Inc. The Company's common shares commenced trading yesterday on the OTCQB...

Subscribe to Biotech News